Expression of galectin-9 mRNA in hepatocellular carcinoma
- PMID: 26823850
- PMCID: PMC4713636
Expression of galectin-9 mRNA in hepatocellular carcinoma
Abstract
Liver cancer, with a very high prevalence, is one of the most common causes of death worldwide. Galectin-9, a semi-galactoside-binding protein, was demonstrated to be involved in the formation and metastasis processes of tumors such as breast cancer, and has significant impact on the development and prognosis of tumor. In this study, 90 cases of liver cancer patients who had liver cancer resection surgery treatment, were selected. Samples of liver cancer tissues and cancer-adjacent tissues from the surgery resection of liver cancer patients, which also confirmed by pathology after operation as specimens, were obtained to detect the expression level of Galectin-9 mRNA. The comparing results showed that there were significant differences between the expression of Galectin-9 mRNA in cancer-adjacent tissues and that in cancer tissues (P < 0.05), in terms of pathology differentiation, TNM, and recurrence transfer aspects. However, there were no obvious correlations with gender, age, the size of tumor, and HBsAg. The expression of Galectin-9 mRNA has a close relationship with pathological differentiation, TNM, and recurrence metastasis. Our data presented here provide theoretical basis for new target of liver cancer diagnosis as well as potential prognosis.
Keywords: Galectin-9 mRNA; cancer-adjacent tissues; expression; liver cancer tissues.
Figures
Similar articles
-
[The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].Zhonghua Yi Xue Za Zhi. 2002 Nov 25;82(22):1553-6. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12609066 Chinese.
-
Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma.Asian Pac J Cancer Prev. 2012;13(6):2503-9. doi: 10.7314/apjcp.2012.13.6.2503. Asian Pac J Cancer Prev. 2012. PMID: 22938412
-
Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.Chin Med J (Engl). 2007 Jun 20;120(12):1042-6. Chin Med J (Engl). 2007. PMID: 17637219
-
The expression profiles of the galectin gene family in colorectal adenocarcinomas.Hum Pathol. 2016 Jul;53:105-13. doi: 10.1016/j.humpath.2016.02.016. Epub 2016 Mar 18. Hum Pathol. 2016. PMID: 27001434
-
Role of tissue factor in hepatocellular carcinoma genesis, invasion and metastasis.Chin Med J (Engl). 2011 Nov;124(22):3746-51. Chin Med J (Engl). 2011. PMID: 22340235
Cited by
-
The emerging role of galectins in high-fatality cancers.Cell Mol Life Sci. 2018 Apr;75(7):1215-1226. doi: 10.1007/s00018-017-2708-5. Epub 2017 Nov 8. Cell Mol Life Sci. 2018. PMID: 29119229 Free PMC article. Review.
-
Galectin-9 in Gastroenterological Cancer.Int J Mol Sci. 2023 Mar 24;24(7):6174. doi: 10.3390/ijms24076174. Int J Mol Sci. 2023. PMID: 37047155 Free PMC article. Review.
References
-
- Liu YM, Chen Y, Li JZ, Gong JP. Up-regulation of Galectin-9 in vivo results in immunosuppressive effects and prolongs survival of liver allograft in rats. Immunol Lett. 2014;162:217–22. - PubMed
-
- Ju Y, Shang X, Liu Z, Zhang J, Li Y, Shen Y, Liu Y, Liu C, Liu B, Xu L, Wang Y, Zhang B, Zou J. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis. Mol Immunol. 2014;58:85–91. - PubMed
-
- Gu CJ, Wu H, Sheng CY, Ni QC. [Expression and prognostic value of galectin-9 in hepatocellular carcinoma patients] . Zhonghua Yi Xue Za Zhi. 2013;93:2025–8. - PubMed
-
- Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, McWilliams R, Randall JA, McMahan R, Zimmerman MA, Rangachari M, Dobrinskikh E, Busson P, Polyak SJ, Hirashima M, Rosen HR. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS One. 2010;5:e9504. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials